Skip to content

Opioid Titration in the Hospice Setting: Barriers Assessment and Modification of the Model Order Sheet and Protocol

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01230515
Enrollment
65
Registered
2010-10-29
Start date
2006-01-31
Completion date
2008-03-31
Last updated
2012-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer Pain

Keywords

Oncology Pain Management in outpatient hospice setting

Brief summary

The purpose of this study is to modify the opioid titration order sheet to meet the needs of the outpatient hospice population and to conduct a pilot trial to assess feasibility, utility, and derive preliminary efficacy data.

Interventions

OTHERIndividual patient interview, focus group and structured survey
OTHERinterview, focus group and structured survey

Sponsors

National Cancer Institute (NCI)
CollaboratorNIH
Vanderbilt-Ingram Cancer Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Patient eligibility includes: * Alive Hospice outpatient * Diagnosis of carcinoma * Pain requiring fixed dose opioids * Age \> 21 years * Not pregnant or lactating * Willing and able to sign informed consent * Able to speak/comprehend English Caregiver eligibility will include: * Caregiver for an Alive Hospice patient * Willing and able to sign informed consent * Able to speak/comprehend English Hospice Staff eligibility will include: * Currently on staff at Alive Hospice * Willing and able to sign informed consent * Able to read/speak English. Referring Physician eligibility will include: * Having recently referred patients to Alive Hospice * Willing and able to sign informed consent and able to read/speak English.

Exclusion criteria

* patients \< 21 years of age * pregnant or lactating * patients, caregiver and or Hospice staff that does not speak/comprehend English

Design outcomes

Primary

MeasureTime frame
Adequate pain controlUntil death.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026